Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F88RV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,593
Award facts
- Contract value 100% obligated
- $18,592.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,592.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on February 4, 2026, with completion scheduled for February 5, 2026. The award was made on a competitive, non-set-aside basis and represents a single task order drawn from a larger indefinite delivery contract vehicle. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with the work performed at its corporate office location in the same city. The company is ultimately owned by parent organization Cencora, Inc., which operates under the AmerisourceBergen brand name.
This delivery order supports the Defense Logistics Agency's Troop Support Medical Supply Chain in furnishing critical pharmaceutical products to military healthcare systems worldwide. The order falls under a substantial indefinite delivery contract valued at $999,999,999 extending through December 2026, which enables AmerisourceBergen to supply a comprehensive portfolio of medications, medical devices, and healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare programs. Cosentyx, a specialty immunosuppressant medication used primarily for autoimmune conditions, reflects the type of specialized pharmaceutical commodity that the broader contract vehicle is designed to deliver efficiently to federal medical facilities.
Quick answers
Who was awarded contract SPE2DR26F88RV?
SPE2DR26F88RV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F88RV worth?
The government has obligated $18,593 on SPE2DR26F88RV.
Is contract SPE2DR26F88RV an order under another contract?
Yes. SPE2DR26F88RV is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88RV competed?
The extent of competition for SPE2DR26F88RV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award